University of Cambridge > > Science@Darwin > Immuno-oncology – current activities and future opportunities

Immuno-oncology – current activities and future opportunities

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Claus Bendtsen.

As part of our Science@Darwin seminars we are hosting a session on immuno-oncology with a focus on some of our current activities as well as what we see as future opportunities.

Come along and hear from some of our leading scientist about: • Immuno-oncology Background Science and Durvalumab (MEDI4736), an anti–PD-L1 antibody by Robert Wilkinson • Targeted therapies: preclinical assessment of immunobiology and combination potential with checkpoint inhibitors by Edd Poon • Small molecule opportunities to enhance anti-tumour immunity and the tumour microenvironment by Simon Barry

We will open the doors from 4.00pm, talks 4.30pm-6pm followed by general networking and refreshments. Please register at

This talk is part of the Science@Darwin series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2024, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity